Ampio Pharmaceuticals
AMPE
#10731
Rank
A$0.25 M
Marketcap
A$0.22
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Ampio Pharmaceuticals (AMPE)

Earnings in 2023 (TTM): -A$12.93 Million

According to Ampio Pharmaceuticals's latest financial reports the company's current earnings are N/A. , an increase over its 2022 earnings that were of -A$23.67 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ampio Pharmaceuticals from 2007 to 2023

Annual earnings

Year Earnings Change
2023 -A$12.51 Million-47.14%
2022 -A$23.67 Million-4.36%
2021 -A$24.74 Million7.42%
2020 -A$23.03 Million16.62%
2019 -A$19.75 Million-140.1%
2018 A$49.24 M-165.49%
2017 -A$75.19 Million170.77%
2016 -A$27.77 Million-30.16%
2015 -A$39.76 Million-29.73%
2014 -A$56.58 Million59.2%
2013 -A$35.54 Million111.58%
2012 -A$16.8 Million-36.57%
2011 -A$26.48 Million127.2%
2010 -A$11.66 Million758.38%
2009 -A$1.36 Million3105.94%
2008 -A$0.05 Million0.79%
2007 -A$0.05 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$48.61 B-388,793.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$14.76 B-118,172.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$12.26 B-98,176.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$7.57 B-60,696.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Rigel Pharmaceuticals
RIGL
A$0.17 B-1,512.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
-A$0.12 Billion 819.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-A$33.68 Million 169.24%๐Ÿ‡บ๐Ÿ‡ธ USA